zytiga tablet 250 mg
johnson & johnson international (singapore) pte ltd - abiraterone acetate - tablet - 250mg - abiraterone acetate 250mg
teropros film coated tablet 1000mg
sandoz singapore pte. ltd. - abiraterone acetate - tablet, film coated - abiraterone acetate 1000.00mg
teropros film coated tablet 250mg
sandoz singapore pte. ltd. - abiraterone acetate - tablet, film coated - abiraterone acetate 250.00mg
teropros film coated tablet 500mg
sandoz singapore pte. ltd. - abiraterone acetate - tablet, film coated - abiraterone acetate 500.00mg
zytiga 250 mg
j-c health care ltd - abiraterone acetate - tablets - abiraterone acetate 250 mg - abiraterone - abiraterone - zytiga is a cyp17 inhibitor indicated:- in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.- for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt).
zytiga
janssen-cilag international n.v. - abiraterone acetate - prostatic neoplasms - endocrine therapy - zytiga is indicated with prednisone or prednisolone for:the treatment of metastatic castration resistant prostate cancer in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of metastatic castration resistant prostate cancer in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
zytiga 500mg tablets
janssen-cilag ltd - abiraterone acetate - tablet - 500mg
zytiga tablets
janssen-cilag s.p.a. - abiraterone (abiraterone acetate) - tablets - 250mg
zytiga film-coated tablet 500mg
johnson & johnson international (singapore) pte ltd - abiraterone acetate - tablet, film coated - abiraterone acetate 500mg
abiraccord tablets 250 mg
accord healthcare private limited - abiraterone acetate - tablet - abiraterone acetate 250 mg